Role of lens in early refractive development: evidence from a large cohort of Chinese children
British Journal of Ophthalmology · 2024
DOI: 10.1136/bjo-2023-324882 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Xiaotong Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Biometry, Lens, Crystalline, Refraction, Ocular. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: National Natural Science Foundation of China, the Construction Project of High-Level Hospitals in Guangdong Province.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Aims
To document longitudinal changes in spherical equivalent refraction (SER) and related biometric factors during early refractive development.
Methods
This was a prospective cohort study of Chinese children, starting in 2018 with annual follow-ups. At each visit, children received cycloplegic autorefraction and ocular biometry measurements. Lens power (LP) was calculated using Bennett’s formula. Children were divided into eight groups based on baseline age: the 3-year-old (n=426, 49.77% girls), 4-year-old (n=834, 47.36% girls), 6-year-old (n=292, 46.58% girls), 7-year-old (n=964, 43.46% girls), 9-year-old (n=981, 46.18% girls), 10-year-old (n=1181, 46.32% girls), 12-year-old (n=504, 49.01%) and 13-year-old (n=644, 42.70%) age groups.
Results
This study included right-eye data from 5826 children. The 3-year-old and 4-year-old age groups demonstrated an inflection point in longitudinal SER changes at a mild hyperopic baseline SER (+1 to +2 D), with children with more myopic SER showing hyperopic refractive shifts while those with more hyperopic SER showing myopic shifts. The hyperopic shift in SER was mainly attributed to rapid LP loss and was rarely seen in the older age groups. Axial elongation accelerated in the premyopia stage, accompanied by a partially counter-balancing acceleration of LP loss. For children aged 3–7 years, those with annual SER changes
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocul…
- Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China.
- School Health Unit, Guangzhou Center for Disease Control and Prevention, Guangzhou, Guangdong, China.
- Experimental Ophthalmology, The Hong Kong Polytechnic University, Hong Kong, China.
- Research School of Biology, Australian National University, Canberra, Australian Capital Territory, Australia.
ORCID-Profile: Xiaotong Han, Ruilin Xiong, Ian Morgan, Yangfa Zeng
Förderung
- National Natural Science Foundation of China
- the Construction Project of High-Level Hospitals in Guangdong Province
Zitieren
APA
Han, X., Xiong, R., Jin, L., Chang, S., Chen, Q., Wang, D., Chen, X., Qu, Y., Liu, W., He, M., Morgan, I., Zeng, Y., & Liu, Y. (2024). Role of lens in early refractive development: evidence from a large cohort of Chinese children. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2023-324882
Vancouver
Han X, Xiong R, Jin L, Chang S, Chen Q, Wang D, et al. Role of lens in early refractive development: evidence from a large cohort of Chinese children. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2023-324882
BibTeX
@article{Han2024,
author = {Han, Xiaotong and Xiong, Ruilin and Jin, Ling and Chang, Shuai and Chen, Qianyun and Wang, Decai and Chen, Xiang and Qu, Yabin and Liu, Weijia and He, Mingguang and Morgan, Ian and Zeng, Yangfa and Liu, Yizhi},
title = {Role of lens in early refractive development: evidence from a large cohort of Chinese children},
journal = {British Journal of Ophthalmology},
year = {2024},
doi = {10.1136/bjo-2023-324882}
}
EUVIMED